Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-Blind Study of IDEC-C2B8 in Childhood-Onset Complicated FRNS or SDNS
jRCT2091220020Completed
- Sponsor
- Kobe University Hospital
- Start
- Sep 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Randomised, double-blind trial in Idiopathic nephrotic syndrome (INS) comparing IDEC-C2B8 (rituximab) with Placebo (2 arms). Primary endpoints: Relapse-free period and Safety endpoints. Started Sep 2008; status: completed.
02
Drugs
rituximab
03
Conditions
Idiopathic nephrotic syndrome (INS)
Beyond the preview
Go deeper on jRCT2091220020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2091220020.